ALX ONCOLOGY HOLDINGS INC (ALXO) Operating income 2018–2025
ALX ONCOLOGY HOLDINGS INC (ALXO) annual operating income history from SEC filings — each fiscal year as reported.
-$104.0MFY2025 · since FY2018: -$13.7M → -$104.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$104.0M | +27.0% |
| FY2024 | -$142.5M | +16.3% |
| FY2023 | -$170.3M | -33.6% |
| FY2022 | -$127.4M | -52.5% |
| FY2021 | -$83.6M | -91.4% |
| FY2020 | -$43.7M | -127.6% |
| FY2019 | -$19.2M | -40.2% |
| FY2018 | -$13.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALXO financial trends
ALXO RevenueALXO Net incomeALXO Net marginALXO Gross profitALXO Gross marginALXO Operating marginALXO Operating cash flowALXO Free cash flowALXO Capital expendituresALXO Return on equityALXO Stock buybacksALXO Dividends paidALXO Total assetsALXO Total liabilitiesALXO Shareholders’ equityALXO overview →